Grifols | GRFS - Beban Penjualan Dan Administrasi

Harga Saham
7.65
Perubahan Harian
0.07 0.92%
Bulanan
-15.66%
Tahunan
-1.80%
Q1 Perkiraan
7.36




Beban Penjualan Dan Administrasi Perubahan Tanggal
Alaunos Therapeutics USD 585K 84K 2025-09
Arca Biopharma USD 2.23M 1.08M 2025-12
aTyr Pharma USD 82.26M 77.46M 2025-12
Bio Path USD 199K 300K 2025-09
Brainstorm Cell Therapeutics USD 1.07M 64K 2025-09
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cara Therapeutics USD 4.64M 2.19M 2025-03
Esperion Therapeutics USD 39.42M 456K 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Immunic USD -0.24 0.03 2024-09
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
TherapeuticsMD USD 1.23M 90K 2024-06